JB Chem is the preferred pick in Pharma sector due to its aggressive growth focus in the domestic market, strong financials &healthy FCF. Its units are low risk with no USFDA inspections since 2019. No product recall or serious complaints in last 14 years
JB Chem is a steady performer going from strength to strength. The stock has given 600% gain in 5 years & 28% YoY. It is almost debt-free, has RoE of 18%. TTM P/E of 41x is lower than Sun Pharma (58) but higher than Cipla (35), Divis (30)…
JB Chemicals is the preferred pick in the Pharma sector: Nirmal Bang
| Subscribe To Our Free Newsletter |
